社区劣势与神经炎症及神经退行性生物标志物的关联
研究纳入334名社区老年人,基线测量区域剥夺指数(ADI),并纵向采集血和脑脊液生物标志物,平均随访6.4年(血)和4.0年(脑脊液)。横断面分析显示ADI越高与脑脊液YKL-40和tau升高相关,纵向分析显示ADI越高与血浆CRP增长更快相关。提示社区劣势可能通过系统性炎症和AD病理机制影响健康差异。
要点
- 社区劣势(ADI)横断面与脑脊液YKL-40和tau升高相关。
- 社区劣势纵向与血浆CRP增长更快相关。
- 结果提示社区劣势可能通过炎症和AD病理影响认知老化。
核心结论
- 更大的社区劣势与横断面脑脊液炎症和AD生物标志物升高及纵向非特异性血炎症标志物增加相关。
研究设计与样本
- 研究为横断面和纵向观察性设计,纳入范德堡记忆与老化项目的334名社区老年人,平均年龄73±8岁,59%男性,86%非西班牙裔白人。
- 基线用区域剥夺指数(ADI,17个成分)量化社区劣势,随访9年,平均随访血6.4年、脑脊液4.0年。
主要发现
- 基线ADI每增加一个单位,横断面脑脊液YKL-40升高β=0.7(p=0.003),脑脊液tau升高β=1.8(p=0.04),均排除离群值后。
- 基线ADI与纵向血浆CRP增长更快相关(β=0.005,p=0.03)。
- 未报告ADI与脑脊液Aβ42、Aβ40/Aβ42比值、ptau、sTREM2及血浆/脑脊液NfL的显著关联。
临床怎么用
- 社区劣势可作为老年人系统性炎症和AD病理风险的潜在社会决定因素,提示临床评估时应关注居住环境。
- 脑脊液YKL-40和tau及血浆CRP可能作为社区劣势相关生物学效应的候选标志物,但尚需验证。
局限性
- ADI仅在研究入口时测量,无法反映社区劣势随时间的变化。
- 样本平均来自相对较不劣势的社区(ADI全国十分位=33±25,范围1-98),限制推广。
- 样本以白人为主(86%),结果可能不适用于其他种族/族裔群体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Living in a socioeconomically disadvantaged neighborhood has an adverse impact on health outcomes, including increased risk of Alzheimer disease (AD). The biological mechanisms underlying this risk are poorly understood. We sought to examine how neighborhood disadvantage relates to core AD pathology, neurodegeneration, and inflammatory biomarkers in community-dwelling older adults cross-sectionally and over time. METHODS: Participants included older adults from the Vanderbilt Memory and Aging Project who underwent fasting blood and CSF acquisition serially over a 9-year follow-up period (mean follow-up = 6.4 years [blood] and 4.0 years [CSF]). Area Deprivation Index (ADI), representing neighborhood disadvantage, was quantified at baseline using 17 components (e.g., housing, income, education, and household characteristics), with higher values indicating greater disadvantage. Ordinary least-squares regressions cross-sectionally related ADI to plasma and CSF inflammatory biomarkers adjusting for age, sex, race/ethnicity, education, modified Framingham Stroke Risk Profile score, APOE ε4 status, and cognitive status. Linear mixed-effects regression models related ADI to longitudinal biomarkers with identical covariates plus follow-up time. Outcomes included CSF chitinase-3-like protein 1 (YKL-40), CSF soluble-triggering receptor expressed on myeloid cells 2, CSF amyloid-β42 (Aβ42), CSF Aβ40/Aβ42 ratio, CSF tau, CSF phosphorylated tau (ptau), plasma high-sensitivity C-reactive protein (CRP), and plasma and CSF neurofilament light chain. RESULTS: Participants (n = 334; 73 ± 8 years old, 59% male, 86% White, non-Hispanic) on average were from relatively less disadvantaged neighborhoods (ADI national decile = 33 ± 25, range = 1-98). Greater neighborhood disadvantage at study entry was cross-sectionally associated with elevated CSF YKL-40 (β = 0.7, p = 0.003) and tau (β = 1.8, p = 0.04) after excluding outliers. Greater neighborhood disadvantage at study entry related to faster longitudinal increases in plasma CRP (β = 0.005, p = 0.03). DISCUSSION: Greater neighborhood disadvantage was associated with elevated inflammatory and AD CSF biomarkers cross-sectionally and longitudinal increases in a nonspecific inflammatory blood biomarker. Findings suggest that neighborhood disadvantage confers risk of systemic inflammation and AD pathology, providing a possible sociobiological mechanism underlying health disparities in aging adults; however, results were limited by use of ADI at study entry.
引用
- Gogniat MA, Khan OA, Ratangee B, et al. Cross-Sectional and Longitudinal Associations of Neighborhood Disadvantage With Fluid Biomarkers of Neuroinflammation and Neurodegeneration. Neurology. 2025. PMID: 40561381. doi:10.1212/WNL.0000000000213770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。